Comparative study of lipid profile abnormalities in first episode and relapse cases of childhood nephrotic syndrome


  • Sreenivasa B. Department of Pediatrics, Basaveshwara Medical College Hospital and Research Centre, Chitradurga, Karnataka
  • Manjunatha B. Department of Pediatrics, Basaveshwara Medical College Hospital and Research Centre, Chitradurga, Karnataka
  • Nivil Joseph Department of Pharmacy Practice, SJM College of Pharmacy, Chitradurga, Karnataka



Cholesterol, Lipoprotein, Nephrotic syndrome


Background: Nephrotic syndrome (NS) is an important chronic renal disease in children, characterized by minimal change disease in the majority of cases. The objective was to study the levels of serum cholesterol, serum triglycerides, LDL VLDL and HDL in nephrotic syndrome at the onset and during remission in first episode and relapse cases.

Methods: A prospective study which included 50 children with steroid sensitive nephrotic syndrome, aged between 2-12 years. Out of which 35 children were presented as first episode, and 15 children as relapse cases. They were clinically examined and lipid profile was done at the onset and during remission. 30 age matched controls without liver and kidney disorders were taken as controls.

Results:There was statistically significant increase in serum cholesterol, triglycerides, LDL and VLDL in nephrotic syndrome patients when compared to controls (P ≤0.005), but HDL value was not significant (P = 0.234). In first episode of nephrotic syndrome cases serum lipids decreased significantly during remission, but HDL was increased during remission and it was not statistically significant, whereas in relapse cases even during remission serum lipids were significantly higher but HDL increase was not statistically significant. There was an inverse correlation between albumin and cholesterol. The correlation was statistically highly significant (P = 0.000).

Conclusions:The present study shows that in nephrotic syndrome, there is generalized hyperlipidemia (except HDL). This was significantly higher in relapse cases compared to first episode. Lipid profiles reaches normal during remission in first episode, whereas in relapse cases it was significantly higher even during remission. Hence there is a rationale for treatment.



Bagga A, Mantan M. Nephrotic syndrome in children. Indian J Med Res. 2005;122:13-28.

Merouani A, Levy E, Mongeau JG, Robitaille P, Lambert M, Delvin EE. Hyperlipidemic profiles during remission in childhood idiopathic nephrotic syndrome. Clinic Biochem. 2003;36:571-4.

Wheeler DC, Bernard DB. Lipid abnormalities in the nephrotic syndrome: causes, consequences and treatment. Am J Kidney Dis. 1994;23:331-46.

Shakir FK, Audilet D, Almond J, Drake, Shakir KM. A rapid protein determination by modification of the lowry procedure. Anal Biochem. 1994;216:232-3.

Wootton IDP. Microanalysis of medical biochemistry. Postgrad Med J.1957;33(380):297.

Varley H, Gowenlock AH, Bell M. Practical Clinical Biochemistry. Fifth Edition; Jaypee Brothers. India.1991:1:126-8.

Searcy RL, Bergquist LM. A new color reaction for the quantitation of serum cholesterol. Clin Chem Acta. 1960;5:192-9.

Fletcher MJ. A colorimetric method for estimating serum triglycerides. Clin Chem Acta. 1968;22:393-7.

Charles J, Stewart M. Colorimetric determination of Phospholipids with ammonium ferrothocyanate. Anal Biochem. 1980;104:10-4.

Appel GB, Blum CB, Chien S, Kunis CL, Appel AS. The hyperlipidemia of the nephrotic syndrome. Relation to plasma albumin concentration, oncotic pressure, and viscosity. New England J Med. 1985;312:1544-8.

Joven J, Villabona C, Vilella E, Masana L, Alberti R, Valles M. Abnormalities of lipoprotein metabolism in patients with the nephrotic syndrome. New England J Med. 1990;323:579-84.

Ohta T, Matsuda I. Lipid and apolipoprotein levels in patients with nephrotic syndrome. Clinica chimica acta. Int J Clinic Chemistry. 1981;117:133-43.

Alexander JH, Schapel GJ, Edwards KD. Increased incidence of coronary heart disease associated with combined elevation of serum triglyceride and cholesterol concentrations in the nephrotic syndrome in man. Med J Australia. 1974;2:119-22.

Arije A, Erasmus RT, Anjorin SA. Plasma lipids and lipoproteins cholesterol distributions in nephrotic syndrome patients during short term steroid treatment. Cent Afr J Med. 1993;39:211-5.

Milne M. Biochemical disorders in human disease. 2nd edition. London: Churchill Ltd. 1976:258-260.

Dnyanesh DK, Dnyanesh S, Shenoy V. A study of serum lipids in nephrotic syndrome in children. IOSR-JDMS. 2014;13(3):1-6

Jensen H. Plasma protein and lipid pattern in the nephrotic syndrome. Acta medica Scandinavica. 1967;182:465-73.

Joven J, Prat RJ, Espinel E, Ras MR, Piera L. High-density lipoproteins in untreated idiopathic nephrotic syndrome without renal failure. Nephrology, dialysis, transplantation: official publication of the European dialysis and transplant association. European Renal Asso. 1987;2:149-53.

Mahmud S, Jahan S, Hossain MM. Hyperlipidemia in childhood idiopathic nephritic syndrome during initial remission and relapse. Mymensingh Med J. 2011;20:402-6.

Krishnaswamy D, Indumati V, Sathishkumar D, Vijay V, Shekanawar M. Serum proteins, initial and follow up lipid profile in children with nephritic syndrome. Int J Applied Bio Pharma Tech. 2011;2:59-64.

Thomas EM, Rosenblum AH, Lander HB, Fisher R. Relationship between blood lipid and blood protein levels in nephrotic syndrome. AMA Am J Dis Child. 1951;81(2):207-14.






Original Research Articles